These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15598006)
1. Proper dose, preparation, and storage of botulinum neurotoxin serotype A. Anderson ER Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S24--9. PubMed ID: 15598006 [TBL] [Abstract][Full Text] [Related]
2. Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage. Gartlan MG; Hoffman HT Otolaryngol Head Neck Surg; 1993 Feb; 108(2):135-40. PubMed ID: 8441537 [TBL] [Abstract][Full Text] [Related]
3. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation. Alam M; Yoo SS; Wrone DA; White LE; Kim JY J Am Acad Dermatol; 2006 Aug; 55(2):272-5. PubMed ID: 16844511 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit. Jabor MA; Kaushik R; Shayani P; Ruiz-Razura A; Smith BK; Morimoto KW; Cohen BE Plast Reconstr Surg; 2003 Jun; 111(7):2419-26; discussion 2427-31. PubMed ID: 12794491 [TBL] [Abstract][Full Text] [Related]
5. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685 [TBL] [Abstract][Full Text] [Related]
6. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox. Yang GC; Chiu RJ; Gillman GS Arch Facial Plast Surg; 2008; 10(4):273-9. PubMed ID: 18645097 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of botulinum neurotoxin serotype A. Wenzel RG Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004 [TBL] [Abstract][Full Text] [Related]
8. Absence of bacterial or fungal growth in vials of reconstituted botulinum toxin type A after storage. Osaki T; Osaki MH; Osaki TH; Sant'Anna AE; Yu MC; Hofling-Lima AL Aesthet Surg J; 2015 Feb; 35(2):189-93. PubMed ID: 25717119 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A: is it really that fragile a molecule? Shome D; Nair AG; Kapoor R; Jain V Dermatol Surg; 2010 Dec; 36 Suppl 4():2106-10. PubMed ID: 21134042 [TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Hexsel DM; De Almeida AT; Rutowitsch M; De Castro IA; Silveira VL; Gobatto DO; Zechmeister M; Mazzuco R; Zechmeister D Dermatol Surg; 2003 May; 29(5):523-9; discussion 529. PubMed ID: 12752522 [TBL] [Abstract][Full Text] [Related]
11. Recommendations and current practices for the reconstitution and storage of botulinum toxin type A. Liu A; Carruthers A; Cohen JL; Coleman WP; Dover JS; Hanke CW; Moy RL; Ozog DM J Am Acad Dermatol; 2012 Sep; 67(3):373-8. PubMed ID: 22055283 [TBL] [Abstract][Full Text] [Related]
12. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin. Fan KL; Wang YL; Chu G; Leung LP J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174 [TBL] [Abstract][Full Text] [Related]
13. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use. Parsa AA; Lye KD; Parsa FD Aesthetic Plast Surg; 2007; 31(2):188-91; discussion 192-3. PubMed ID: 17122996 [TBL] [Abstract][Full Text] [Related]
14. [Conversion ratio between different botulinum neuroprotein product in neurological practice]. Orlova OR; Timerbaeva SL; Khatkova SE; Kostenko EV; Krasavina DA; Zakharov DV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):132-141. PubMed ID: 29053134 [TBL] [Abstract][Full Text] [Related]
15. Recovery from botulinum neurotoxin poisoning in vivo. Keller JE Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322 [TBL] [Abstract][Full Text] [Related]
16. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections. Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489 [TBL] [Abstract][Full Text] [Related]
17. Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin. Sheridan RE; Deshpande SS; Amersdorfer P; Marks JD; Smith T Toxicon; 2001 May; 39(5):651-7. PubMed ID: 11072043 [TBL] [Abstract][Full Text] [Related]
18. Generalized botulism: diagnostic problems in a patient treated with botulinum toxin type A. Acta Ophthalmol Scand; ; . PubMed ID: 17305749 [No Abstract] [Full Text] [Related]